These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38751758)

  • 21. Adapting Provider Training and Pre-Exposure Prophylaxis Advertising to Increase Pre-Exposure Prophylaxis Awareness and Uptake Among Black Cisgender Women.
    Devlin SA; Ridgway JP; Dawdani A; Enaholo OE; Liegeon G; Kasal N; Pyra M; Hirschhorn LR; Simon J; Haider S; Ducheny K; Johnson AK
    AIDS Patient Care STDS; 2023 Dec; 37(12):574-582. PubMed ID: 38011350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV self-testing and oral pre-exposure prophylaxis are empowering for sex workers and their intimate partners: a qualitative study in Uganda.
    Mujugira A; Nakyanzi A; Kasiita V; Kamusiime B; Nalukwago GK; Nalumansi A; Twesigye CC; Muwonge TR; Baeten JM; Wyatt MA; Haberer JE; Ware NC
    J Int AIDS Soc; 2021 Sep; 24(9):e25782. PubMed ID: 34473405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding Retention in the HIV Pre-Exposure Prophylaxis Cascade Among Cisgender Women.
    Burns JA; Hull SJ; Inuwa A; Moriarty P; Scott RK
    AIDS Patient Care STDS; 2023 Apr; 37(4):205-211. PubMed ID: 36961388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Associated With Willingness to Use Pre-Exposure Prophylaxis in Brazil, Mexico, and Peru: Web-Based Survey Among Men Who Have Sex With Men.
    Torres TS; Konda KA; Vega-Ramirez EH; Elorreaga OA; Diaz-Sosa D; Hoagland B; Diaz S; Pimenta C; Bennedeti M; Lopez-Gatell H; Robles-Garcia R; Grinsztejn B; Caceres C; Veloso VG;
    JMIR Public Health Surveill; 2019 Jun; 5(2):e13771. PubMed ID: 31210143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "You Never Know What Could Happen": Women's Perspectives of Pre-Exposure Prophylaxis in the Context of Recent Intimate Partner Violence.
    Willie TC; Keene DE; Kershaw TS; Stockman JK
    Womens Health Issues; 2020; 30(1):41-48. PubMed ID: 31537431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP.
    Calabrese SK; Willie TC; Galvao RW; Tekeste M; Dovidio JF; Safon CB; Blackstock O; Taggart T; Kaplan C; Caldwell A; Kershaw TS
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):395-405. PubMed ID: 30973543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multilevel Factors Shaping Awareness of and Attitudes Toward Pre-exposure Prophylaxis for HIV Prevention among Criminal Justice-Involved Women.
    Dauria EF; Levine A; Hill SV; Tolou-Shams M; Christopoulos K
    Arch Sex Behav; 2021 May; 50(4):1743-1754. PubMed ID: 33236275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake of and intention to use oral pre-exposure prophylaxis for HIV among pregnant and post-natal women in Eswatini: a cross-sectional survey.
    Khumalo PN; Mkhonta SS; Kindandi K; Matse S; Dlamini PB; Tukei V; Machekano R; Woelk G
    Front Reprod Health; 2023; 5():1253384. PubMed ID: 37965589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perceived need of, and interest in, HIV pre-exposure prophylaxis amongst men who have sex with men attending three sexual health clinics in London, UK.
    Bull L; Dimitrijevic P; Beverley S; Scarborough A; Mandalia S; Dosekun O; Barber T; Reeves I; McCormack S; Rayment M
    Int J STD AIDS; 2018 Apr; 29(5):435-442. PubMed ID: 28927341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Associated with Comfort Discussing PrEP with Healthcare Providers among Black Cisgender Women.
    Irie WC; Mahone A; Nakka R; Ghebremichael M
    Trop Med Infect Dis; 2023 Sep; 8(9):. PubMed ID: 37755897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beliefs Associated with Intention to Use PrEP Among Cisgender U.S. Women at Elevated HIV Risk.
    Teitelman AM; Chittamuru D; Koblin BA; Davis A; Brawner BM; Fiore D; Broomes T; Ortiz G; Lucy D; Tieu HV
    Arch Sex Behav; 2020 Aug; 49(6):2213-2221. PubMed ID: 32270399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Social and structural factors associated with interest in HIV preexposure prophylaxis among Black women in the United States.
    Irie WC; Calabrese SK; Mayer KH; Geng EH; Blackstock O; Marcus JL
    AIDS Care; 2024 May; 36(5):672-681. PubMed ID: 38176016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying Implementation Strategies to Enhance HIV Pre-Exposure Prophylaxis Uptake Among Black Cisgender Women in New Orleans, Louisiana.
    Clement ME; Perry B; McKenna K; Beckford J; Davenport T; Murray E; Magee V; Bickham JN; Siren J; Smith A; Lillis R; Corneli A
    AIDS Patient Care STDS; 2024 Mar; 38(3):144-150. PubMed ID: 38471093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring HIV Preexposure Prophylaxis Use Among Men Who Have Sex With Men in Washington State: Findings From an Internet-Based Survey.
    Rao DW; Carr J; Naismith K; Hood JE; Hughes JP; Morris M; Goodreau SM; Rosenberg ES; Golden MR
    Sex Transm Dis; 2019 Apr; 46(4):221-228. PubMed ID: 30870322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment.
    Ni Z; Altice FL; Wickersham JA; Copenhaver MM; DiDomizio EE; Nelson LE; Shrestha R
    Drug Alcohol Depend; 2021 Feb; 219():108477. PubMed ID: 33422864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mandrax use, sexual risk, and opportunities for pre-exposure prophylaxis among out-of-school adolescent girls and young women in Cape Town, South Africa.
    Bonner CP; Browne FA; Carney T; Shangase N; Ndirangu JW; Myers B; Wechsberg WM
    S Afr Med J; 2022 Apr; 112(5):341-346. PubMed ID: 35587247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discomfort discussing HIV/AIDS and lack of awareness are barriers to partner-to-partner pre-exposure prophylaxis education.
    Farthing H; Rodriguez A; Armstrong M; Iyengar S; Nigh E; Potter J; Doblecki-Lewis S
    Int J STD AIDS; 2019 Feb; 30(2):147-153. PubMed ID: 30301426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knowledge and attitude to HIV pre exposure prophylaxis among women in five sub-Saharan African countries: a multilevel model analysis of population-based survey 2021-2022.
    Terefe B; Jembere MM; Asgedom DK; Lakew AM
    BMC Public Health; 2024 May; 24(1):1253. PubMed ID: 38714974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.